Cheng QY - Search Results

1

Mutation status of epidermal growth factor receptor and clinical features of patients with combined small cell lung cancer who received surgical treatment.

Lu HY, Mao WM, Cheng QY, Chen B, Cai JF, Wang XJ, Wang Z, Xie FJ. Lu HY, et al. Among authors: cheng qy. Oncol Lett. 2012 Jun;3(6):1288-1292. doi: 10.3892/ol.2012.666. Epub 2012 Apr 2. Oncol Lett. 2012. PMID: 22783435 Free PMC article.

2

Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer.

Lu HY, Zhang G, Cheng QY, Chen B, Cai JF, Wang XJ, Zhang YP, Wang Z, Lu ZY, Xie FJ, Mao WM. Lu HY, et al. Among authors: cheng qy. Oncol Lett. 2012 Jul;4(1):89-93. doi: 10.3892/ol.2012.679. Epub 2012 Apr 12. Oncol Lett. 2012. PMID: 22807968 Free PMC article.

3

PIK3CA Mutations in Resected Small Cell Lung Cancer.

Han N, Cheng QY, Chen B, Cai JF, Wang XJ, Lou CJ, Qin J, Ye WW, Lei L, Lu HY. Han N, et al. Among authors: cheng qy. Adv Clin Exp Med. 2016 May-Jun;25(3):397-402. doi: 10.17219/acem/25928. Adv Clin Exp Med. 2016. PMID: 27629725 Free article.

4

MGMT promoter methylation and 1p/19q co-deletion of surgically resected pulmonary carcinoid and large-cell neuroendocrine carcinoma.

Lei L, Jiang Z, Zhang G, Cheng Q, Lu H. Lei L, et al. World J Surg Oncol. 2018 Jun 18;16(1):110. doi: 10.1186/s12957-018-1413-7. World J Surg Oncol. 2018. PMID: 29914531 Free PMC article.

5

Identifying EGFR mutations from SCLC patient plasma by mutant-enriched liquidchip technology.

Lu HY, Lu ZY, Cheng QY, Cai JF, Wang XJ, Zhang YP, Lou CJ, Yu XM, Qin J, Ye WW, Lei L, Huang J, Yang HY, Mao WM. Lu HY, et al. Among authors: cheng qy. Adv Clin Exp Med. 2014 Mar-Apr;23(2):191-5. doi: 10.17219/acem/37048. Adv Clin Exp Med. 2014. PMID: 24913109 Free article.

6

[Determination of 7-ethyl-10-hydroxycamptothecin in microdialysates from rat brain with LC-MS/MS].

Cao Y, Cheng Q, Lu H, Zhang H. Cao Y, et al. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013 Jan;42(1):98-102. doi: 10.3785/j.issn.1008-9292.2013.01.016. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2013. PMID: 23505115 Chinese.

7

The Role and Mechanism of Borneol to Open the Blood-Brain Barrier.

Wu T, Zhang A, Lu H, Cheng Q. Wu T, et al. Integr Cancer Ther. 2018 Sep;17(3):806-812. doi: 10.1177/1534735418767553. Epub 2018 Apr 13. Integr Cancer Ther. 2018. PMID: 29652199 Free PMC article.

8

[Brain delivery of neurotoxin-I-loaded nanoparticles through intranasal administration].

Cheng QY, Feng J, Li FZ. Cheng QY, et al. Yao Xue Xue Bao. 2008 Apr;43(4):431-4. Yao Xue Xue Bao. 2008. PMID: 18664209 Chinese.

9

Intracerebral microdialysis technique and its application on brain pharmacokinetic-pharmacodynamic study.

Pan YF, Feng J, Cheng QY, Li FZ. Pan YF, et al. Among authors: cheng qy. Arch Pharm Res. 2007 Dec;30(12):1635-45. doi: 10.1007/BF02977335. Arch Pharm Res. 2007. PMID: 18254253 Review.

10

Microdialysis for pharmacokinetic-pharmacodynamic studies.

Yu W, Cheng Q, Feng J, Li F. Yu W, et al. Pharmazie. 2007 Dec;62(12):883-91. Pharmazie. 2007. PMID: 18214337 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters